Rothschild & Co Asset Management US’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
BG
Rothschild & Co Asset Management US's BSX Position: Q4 2022 in Review
Rothschild & Co Asset Management US increased its Boston Scientific (BSX) stake by 82% in Q4 2022, buying an estimated $43.4M and bringing the position to 2,225,689 shares worth $103M. The position accounts for 1.57% of the portfolio, ranked #17.
Rothschild & Co Asset Management US first reported a position in BSX in Q3 2016 and has held it in 15 quarters since. 929 funds tracked by Wall St. Rank hold BSX as of Q4 2022.
- Rothschild & Co Asset Management US held 2,225,689 shares of Boston Scientific worth $103M as of Q4 2022.
- Rothschild & Co Asset Management US bought 1,001,388 Boston Scientific shares in Q4 2022, an estimated $43.4M.
- Boston Scientific made up 1.57% of Rothschild & Co Asset Management US's portfolio in Q4 2022, its #17 holding.
- Rothschild & Co Asset Management US first reported a position in Boston Scientific in Q3 2016 and has held it in 15 quarters since.
- 929 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2022.
Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.